Trends in the surgical management of renal cell carcinoma in a contemporary tertiary care setting.

Autor: Junejo NN; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; Alfaisal University, College of Medicine, Riyadh, Saudi Arabia., Alkhateeb SS; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; Alfaisal University, College of Medicine, Riyadh, Saudi Arabia., Alrumayyan MF; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alkhatib KY; Alfaisal University, College of Medicine, Riyadh, Saudi Arabia., Alzahrani HM; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alotaibi MF; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; Alfaisal University, College of Medicine, Riyadh, Saudi Arabia., Alothman KI; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Al-Hussain TO; Alfaisal University, College of Medicine, Riyadh, Saudi Arabia.; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Altaweel WM; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; Alfaisal University, College of Medicine, Riyadh, Saudi Arabia.
Jazyk: angličtina
Zdroj: Urology annals [Urol Ann] 2021 Apr-Jun; Vol. 13 (2), pp. 111-118. Date of Electronic Publication: 2021 Mar 04.
DOI: 10.4103/UA.UA_151_20
Abstrakt: Background: In the last three eras, the incidence of renal cell carcinoma (RCC) has increased, due to increased radiological studies. The expected 5-year survival rate has become better, associated with the identification of small size renal masses. However, this survival improvement may be secondary to improved surgical techniques and medical therapies for these malignancies.
Objectives: The objective was to report the trends of clinical presentation, peri-operative, oncological outcomes, and surgical management trends for RCCs over the period.
Methods: After Institutional Review Board approval, a retrospective study for adult patients was conducted, who presented with renal mass and were managed between 2008 and 2019. Variables, including demographics, perioperative and pathological outcomes analyzed using descriptive statistics for continuous variables reported as mean ± standard deviation and categorical variables values compared by Chi-square test. Survival Analysis calculated using the Kaplan-Meier method. The level of significance is set at P-value < 0.05.
Results: A total of 588 patients underwent surgical treatment for kidney cancer from January 2008 to January 2019. 237 (40.30%) were females and 351 (59.69%) males. The clinical presentation was higher as an incidental diagnosis of 58.67%. 71.25% of patients were from outside Riyadh city. Pathology was mostly clear cell RCC 61.22% and grade 2 (57.48%). Tumor size, surgery time, and length of hospital stay showed a significant difference between the three periods (both P > 0.05). Robotic surgery performed more than open ( P < 0.0001). There was no significant difference in the survival time, when compared to patients by the regions and when compared by the primary tumors (Log-Rank P = 0.4821). Patients from the Riyadh region (median = 54.0) had a significantly higher recurrence time (Log-Rank P < 0.0001).
Conclusion: There was a rising trend in the incidence of RCC associated with comorbidities and incidental diagnosis. In our study period we found increase in the trend of minimal invasive approach. The size of the tumor, blood loss and operative time decreases over the period of time. The Robotic assisted nephrectomy approach has become increased over the period of time duration in present study.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2021 Urology Annals.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje